Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
This study has been completed.
Sponsor:
Maastricht Radiation Oncology
Collaborator:
Pfizer
Information provided by:
Maastricht Radiation Oncology
ClinicalTrials.gov Identifier:
NCT00181532
First received: September 13, 2005
Last updated: June 29, 2009
Last verified: June 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2008 |
| Estimated Primary Completion Date: | No date given |